Pityriasis rubra pilaris following booster dose of mRNA (Pfizer-BioNTech) COVID-19 vaccine

Dermatol Ther. 2022 Nov;35(11):e15791. doi: 10.1111/dth.15791. Epub 2022 Sep 7.

Authors

Nika Hlaca^{1

2}, Tina Zagar^{1

2}, Marija Kastelan^{1

2}, Sandra Peternel^{1

2}, Ines Brajac^{1

2}, Katarina Dujmovic-Hasanbegovic^{1

2}, Larisa Prpic-Massari^{1

2}

Affiliations

¹ Department of Dermatovenerology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.
² Faculty of Medicine, University of Rijeka, Rijeka, Croatia.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Humans
Pityriasis Rubra Pilaris*
RNA, Messenger

Substances

COVID-19 Vaccines
RNA, Messenger